107 results on '"Provero, Paolo"'
Search Results
2. Table 1 from miR-146a Exerts Differential Effects on Melanoma Growth and Metastatization
3. Table 2 from miR-146a Exerts Differential Effects on Melanoma Growth and Metastatization
4. Figure S9 from miR-146a Exerts Differential Effects on Melanoma Growth and Metastatization
5. Figure S10 from miR-146a Exerts Differential Effects on Melanoma Growth and Metastatization
6. Figure S1 from miR-146a Exerts Differential Effects on Melanoma Growth and Metastatization
7. Table 2 from miR-146a Exerts Differential Effects on Melanoma Growth and Metastatization
8. Table 1 from miR-146a Exerts Differential Effects on Melanoma Growth and Metastatization
9. Figure S7 from miR-146a Exerts Differential Effects on Melanoma Growth and Metastatization
10. Figure S3 from miR-146a Exerts Differential Effects on Melanoma Growth and Metastatization
11. Figure S8 from miR-146a Exerts Differential Effects on Melanoma Growth and Metastatization
12. Figure S2 from miR-146a Exerts Differential Effects on Melanoma Growth and Metastatization
13. Figure S13 from miR-146a Exerts Differential Effects on Melanoma Growth and Metastatization
14. Figure S15 from miR-146a Exerts Differential Effects on Melanoma Growth and Metastatization
15. Figure S4 from miR-146a Exerts Differential Effects on Melanoma Growth and Metastatization
16. Figure S11 from miR-146a Exerts Differential Effects on Melanoma Growth and Metastatization
17. Figure S6 from miR-146a Exerts Differential Effects on Melanoma Growth and Metastatization
18. Figure S16 from miR-146a Exerts Differential Effects on Melanoma Growth and Metastatization
19. Figure S14 from miR-146a Exerts Differential Effects on Melanoma Growth and Metastatization
20. Supplementary Tables 1 and 2 and Supplementary Figures 1 through 6 from Alternative Polyadenylation in Triple-Negative Breast Tumors Allows NRAS and c-JUN to Bypass PUMILIO Posttranscriptional Regulation
21. Data from Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in Rhabdomyosarcoma
22. Supplementary Table S3 from Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in Rhabdomyosarcoma
23. Supplementary Methods, Results and Tables from Subtype-Specific Metagene-Based Prediction of Outcome after Neoadjuvant and Adjuvant Treatment in Breast Cancer
24. Supplementary Figure Legends from Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in Rhabdomyosarcoma
25. Supplementary Table S1 from Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in Rhabdomyosarcoma
26. Supplementary Table S3 from Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in Rhabdomyosarcoma
27. Supplementary Methods, Results and Tables from Subtype-Specific Metagene-Based Prediction of Outcome after Neoadjuvant and Adjuvant Treatment in Breast Cancer
28. Data from Alternative Polyadenylation in Triple-Negative Breast Tumors Allows NRAS and c-JUN to Bypass PUMILIO Posttranscriptional Regulation
29. Supplementary Figure Legends from Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in Rhabdomyosarcoma
30. Supplementary Materials and Methods from Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in Rhabdomyosarcoma
31. Data from Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in Rhabdomyosarcoma
32. Supplementary Table S2 from Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in Rhabdomyosarcoma
33. Supplementary Figure S3 from Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in Rhabdomyosarcoma
34. Supplementary Figures from Subtype-Specific Metagene-Based Prediction of Outcome after Neoadjuvant and Adjuvant Treatment in Breast Cancer
35. Supplementary Table S1 from Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in Rhabdomyosarcoma
36. Supplementary Figures from Subtype-Specific Metagene-Based Prediction of Outcome after Neoadjuvant and Adjuvant Treatment in Breast Cancer
37. Supplementary Tables 1 and 2 and Supplementary Figures 1 through 6 from Alternative Polyadenylation in Triple-Negative Breast Tumors Allows NRAS and c-JUN to Bypass PUMILIO Posttranscriptional Regulation
38. Supplementary Table S2 from Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in Rhabdomyosarcoma
39. Data from Alternative Polyadenylation in Triple-Negative Breast Tumors Allows NRAS and c-JUN to Bypass PUMILIO Posttranscriptional Regulation
40. Supplementary Data 1 from Expression of the FUS-CHOP Fusion Protein in Primary Mesenchymal Progenitor Cells Gives Rise to a Model of Myxoid Liposarcoma
41. Data from Constitutively Active Stat3 Enhances Neu-Mediated Migration and Metastasis in Mammary Tumors via Upregulation of Cten
42. Figure S2 from miR-214 and miR-148b Targeting Inhibits Dissemination of Melanoma and Breast Cancer
43. Supplementary from miR-214 and miR-148b Targeting Inhibits Dissemination of Melanoma and Breast Cancer
44. Data from Development of Ewing's Sarcoma from Primary Bone Marrow–Derived Mesenchymal Progenitor Cells
45. Data from EWS-FLI-1 Expression Triggers a Ewing's Sarcoma Initiation Program in Primary Human Mesenchymal Stem Cells
46. Figure S1 from miR-214 and miR-148b Targeting Inhibits Dissemination of Melanoma and Breast Cancer
47. Supplemental Figure S1 from Targeting Cancer Stem–like Cells as an Approach to Defeating Cellular Heterogeneity in Ewing Sarcoma
48. Figure S6 from miR-214 and miR-148b Targeting Inhibits Dissemination of Melanoma and Breast Cancer
49. Data from miR-214 and miR-148b Targeting Inhibits Dissemination of Melanoma and Breast Cancer
50. Data from EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.